Intralesional Tetracycline Injection in the Treatment of Chalazia

• Status: Withdrawn
• Trial end date: 2015-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators propose a study to investigate the role of tetracycline injection into chalazia versus observation alone. The investigators hypothesize tetracycline injection will result in a significant decrease in lesion size when compared to observation alone.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: The Cleveland Clinic
• Treatments: Tetracycline

Criteria

Inclusion Criteria:

• Age older than 18 years

• Not pregnant

• Chalazia of greater than 1 week duration

• Not allergic to tetracycline or its derivatives

• Not currently taking tetracycline or not taking them in the past 3 months

Exclusion Criteria:

• Age less than 18 years old

• Pregnancy

• Chalazia of less than 1 week duration

• Allergies to tetracycline or its derivatives

• Currently taking tetracyclines or have taken them in the past 3 months